Skip to main content

Table 2 2000 Cohort / OA/RA vs. OA/RA + CVD medications, by age and sex

From: Using clinical trial data and linked administrative health data to reduce the risk of adverse events associated with the uptake of newly released drugs by older Australians: a model process

Age Group

OA/RA

drugs only

Male

OA/RA

drugs only

Female

% of patients

taking OA/RA

drugs only

OA/RA plus

CVD drugs

Male

OA/RA plus

CVD drugs

Female

% of patients

taking OA/RA

plus CVD drugs

65-69

2,862

3,272

39%

4,427

5,255

61%

70-74

2,528

2,607

32%

4,999

6,035

68%

75-79

1,707

1,980

28%

4,091

5,535

72%

80-84

854

1,175

26%

2,159

3,648

74%

85-99

491

897

24%

1,327

3,119

76%

Sub-totals

8,442

9,931

 

17,003

23,592

 
 

Patient Total = 18,373

Patient Total = 40,595